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Abstract 
Understanding large molecular networks consisting of entities such as genes, proteins or 
RNAs that interact in complex ways to drive the cellular machinery has been an active focus 
of systems biology. Computational approaches have played a key role in systems biology by 
complementing theoretical and experimental approaches. Here we roadmap some key 
contributions of computational methods developed over the last decade in the 
reconstruction of biological pathways. We position these contributions in a ‘systems biology 
perspective’ to reemphasize their roles in unravelling cellular mechanisms and to 
understand ‘systems biology diseases’ including cancer. 
 
 
1. Introduction 
To understand the functional organisation of cells or higher biological units, often it is 
beneficial to conceptualize them as systems of interacting entities. For such a systems-level 
description, one needs to know (a) the entities (“parts list”) that constitute the system, (b) 
the interactions among these entities, and (c) their dynamic behaviour under changes to 
internal and external conditions [1]. The goal of systems biology is to combine all this 
information into models that capture current knowledge and provide new insights and 
predictions about the system under previously unstudied conditions [2]. Early attempts at 
systems biology suffered from inadequate data to build reliable models and formulate 
hypotheses; however, the recent advent of high-throughput technologies has brought the 
initial wave of data to revive systems-level modelling and analysis, thereby seeding a 
revolutionary change in how biology is being studied and understood.   
 
Understanding of complex molecular networks consisting of entities such as genes, proteins 
or RNAs connected by interactions for regulation or synthesis in cellular decision-making 
and responses has become a key focus of systems-level studies. Efficient computational 
approaches can complement theoretical and experimental approaches to model, analyse 
and distil knowledge from high-throughput data. The reconstruction of biological pathways 
through which cellular entities interact, signal and regulate cellular processes is certainly 
one of the fundamental building blocks towards understanding whole biological networks. 
 
 
1.1 Understanding computational methods in a systems biology setting 
 
In order to decipher the correct and complete picture of cellular organisation, it is 
imperative to assess the entire collection of pathways as a whole rather than individually; 
the system as a whole has emergent properties that are not visible at the parts level [3]. 
However the reconstruction of all pathways, together with their intricate network of cross-
talk and feedback loops, is a daunting task. Since pathways do not have definite start and 
end points or distinct boundaries, modeling them computationally is a significant challenge. 
Nevertheless, all computational methods developed to date model pathways as definite 
computable structures such as paths, trees or subnetworks. Under these circumstances, it 
becomes all the more crucial to place these computational methods and their contributions 
in a systems biology setting to assess where we stand in achieving this higher goal of 
systems-level understanding of cellular organisation. 
 
In this article, we roadmap some of the key computational methods devised over the last 
decade for biological pathway reconstruction from high-throughput data. Although we 
mainly look at methods reconstructing regulatory or signalling pathways, this illustrates 
how computational methods have contributed to this area more broadly. While some 
methods have focused on identifying general pathways, others have specifically considered 
dysregulated and disease pathways, while still others have looked at additive, alternative or 
compensatory relationships among pathways. Further, as these methods evolved, so did 
their mechanisms to integrate diverse “omics” data, mainly genomics (gene expression, 
methylation, mutation, regulation, genetic interaction) and proteomics (protein interaction). 
It is both imperative and interesting to put all these developments together and consider 
where we stand in deciphering systems-level molecular networks and evaluate its 
implications. 
 
 
 
 
2. General pathway identification 
 
In an elegant study [4] conducted as early as 2001, Ideker et al. concentrated on a core 
pathway, GAL (galactose utilization), in the yeast Saccharomyces cerevisiae, implementing 
an integrated approach involving molecular expression and interactions to understand how 
its genes are regulated. After assembling the GAL pathway based on available information, 
these authors systematically perturbed each gene and measured the response through 
expression of a global gene set. Around the same time, large-scale protein-protein (PPI) and 
protein-DNA interactions were being catalogued for yeast [5], and this enabled Ideker et al. 
to assemble a global network of ~3000 interactions. This network was used to identify paths 
connecting perturbed GAL genes to every other affected gene. They identified nine genes 
involved in glycogen accumulation and protein metabolism, and several of unknown 
function, that responded strongly to galactose induction. 
 
As more high-throughput protein interaction [5-7] and gene expression data [8] began to 
appear, Steffen et al. [9] in 2002 took a similar approach, assembling a large PPI network to 
draw possible linear paths of specified lengths starting at membrane proteins and ending on 
DNA-binding proteins. They scored these paths using co-expression among adjacent 
proteins to identify high-ranking paths corresponding to known pathways. This method, 
called NetSearch, enabled them to reconstruct the yeast MAPK (mitogen-activated protein 
kinases) pathways involved in pheromone response, filamentous growth, and maintenance 
of cell wall integrity. Similarly, Liu et al. [10] identified candidate sets of proteins in a PPI 
network, and inferred the highest-scoring order among them by measuring gene co-
expression among adjacent proteins in each permutation of the set. With this scoring, they 
could identify the correct ordering among proteins that corresponded to MAPK pathways in 
yeast. In a separate attempt, Friedman et al. [11,12] used a Bayesian framework to learn 
expression profiles of genes perturbed in yeast mutants and used it to infer pairwise 
expression correlation among proteins. Through this they assembled pathways involved in 
purine biosynthesis and non-homologous DNA double strand break repair. 
 
Alongside yeast, large-scale PPI data from prokaryotes including Helicobacter pylori [13] and 
eukaryotes including Caenorhabditis elegans [14] began to appear around 2001-2002, which 
enabled researchers to search in networks for pathways conserved across species. In a 
seminal work of this kind, Kelley et al. [15] in 2003 devised PATHBLAST, an efficient tool to 
align paths across multiple PPI networks. This tool enables search for homologous paths 
across networks by accommodating “gaps” and “mismatches”. They identified 150 
homologous paths of lengths ≥4 among the three species. Further, by self-matching the 
yeast network, Kelley et al. identified about 300 paralogous paths that they grouped into 
several functional pathways. Following this success, Shlomi et al. [16] proposed QPath, 
which improved on the results of PATHBLAST. 
 
In the meantime, as reports [17,18] of high false-positive rates in high-throughput 
experiments began to surface, it became necessary to assess reliability of interactions 
before employing them in focused studies such as pathway identification. In a seminal study 
combining reliability scoring and pathway identification, Scott et al. [19] (2006) assigned a 
score to every interaction in the network by combining three criteria: (a) the number of 
times a protein pair was seen interacting in multiple experiments, (b) the Pearson 
correlation between expression profiles of the proteins, and (c) their small-world clustering 
coefficient. Using the resultant scored network, they devised two algorithms to identify 
pathway structures. The first identified high-scoring simple paths, while the second 
identified more-general structures including rooted trees and ‘series-parallel’ graphs. 
Through experiments on a yeast network of ~4500 proteins and ~14500 interactions, they 
successfully reconstructed several pheromone-response pathways with high accuracy. 
 Aided by computational tools and experimental approaches, the growth of public databases 
including KEGG [20] for pathways and FunCat [21] and Gene Ontology (GO) [22] for 
functional annotations enabled pathway identification methods to use these annotations 
for both prediction and validation of results. Among the first to use such diverse data was 
PathFinder by Bebek et al. [23] in 2007. These authors collected functional annotations from 
FunCat and GO for proteins in KEGG to build functional templates for pathways. They then 
used these templates to mine pathways from the yeast PPI network, and the high-support 
pathways were identified and scored using association rules mining [24]. PathFinder showed 
significantly better accuracy and sensitivity compared to most earlier methods, and 
identified several missing links among proteins in annotated pathways in databases. 
 
In an attempt to identify general substructures beyond linear paths, Zhao et al. [25] in 2008 
devised an integer linear programming (ILP)-based approach to mine the yeast PPI network. 
They modeled pathways as compact subnetworks between fixed starting and ending points. 
These subnetworks were scored using reliability scores on the edges: linear paths were 
scored as the sum of the edges in the paths, while general subnetworks were scored as the 
sum of the constituent edges. An ILP-based model was then proposed to extract high-
scoring subnetworks from the PPI network. Experiments on subnetworks identified between 
membrane proteins and transcription factors showed that many pheromone-response 
pathways and signalling pathways for filamentous growth were reconstructed with high 
accuracy.  
 
Liu et al. [26] (2009) noticed that most signals between proteins (for example activation, 
inhibition, phosphorylation, dephosphorylation and ubiquitination) were directional, so 
identifying the correct direction of interactions among proteins was crucial for accurate 
reconstruction of signalling pathways. They proposed a signal-flow model to orient 
interactions in the PPI network, for which they used domain interaction information among 
proteins. Based on the deduced orientations, they identified potential upstream-
downstream relationships within protein pairs. This method successfully reconstructed 
several signalling pathways from the human PPI network, which matched ones annotated in 
KEGG and other databases. 
 Independent to these approaches, Boolean [27,28], Petri Nets [29] and ordinary differential 
equations (ODEs) [30] are a few other models that were proposed, but these have mainly 
focused on simulation and study of behavior of known pathways as against pathway 
inference from high-throughput datasets. 
 
 
 
 
 
3. Exploring relationships among pathways 
 
As methods to identify pathways improved, it became interesting to understand the 
relationships among different pathways and how they constituted the larger “pathway 
network” to regulate and govern cellular processes. This was further fuelled by the 
realisation that many diseases, including cancer, arise from a complex interplay between 
pathways acting in additive, compensatory or alternative ways to maintain aberrant 
behaviour of cells. While the genomics and proteomics data had already proven useful, the 
availability of genetic-interaction data from systematic knock-out experiments in yeast and 
other organisms [31-33] further aided these studies. 
 
Among the seminal works in this direction, Kelley and Ideker [34] (2005) combined PPI and 
genetic-interaction (GI) networks to understand pathway relationships. They proposed that 
several pathways linking proteins in the PPI network were related by between-pathway 
interactions in the GI network. This between-pathway model (BPM) proposed that such 
pathways are involved in compensatory functions and buffered the loss of one another. 
These pathways form alternative or redundant functional groups to maintain the robustness 
of pathway mechanisms. 
 
BPM prompted further work to look at PPI and GI interactions in an integrated manner to 
decipher such pathway relationships. One of the early works that took this forward was by 
Ulitsky and Shamir [35] (2007), who assembled a large network combining PPI and GI data, 
and systematically searched for BPM structures. They found that several of the pathways in 
KEGG [28] were related by BPM structures, indicating that these pathways functioned in a 
compensatory fashion. BPM relationships between proteins in different complexes with 
‘pivot’ or shared proteins among the complexes were essential to all the host complexes.  
Subsequently Hescott et al. [36] (2009) integrated gene-expression data to evaluate BPM 
structures identified from PPI and GI networks in order to further refine redundant pathway 
identification. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Models of synthetic lethality relationships seen between proteins within and between pathways and 
complexes (adapted from Le Meur and Gentleman [37] with permission from Genome Biology). 
 
 
In this context, a subset of genetic interactions called synthetic lethality (SL) interactions 
have gained immense interest due to their prominence in connecting compensatory 
pathways and functions. Le Meur and Gentleman (2008) [37] analysed the enrichment of SL 
interactions within and between complexes and pathways; most SL interactions were 
between-pathway and -complexes, while a considerable number were also within these 
structures (see Figure 1). These within-complex and -pathway interactions ensured internal 
robustness to these structures by buffering the functions of proteins. In separate work, Ma 
et al. (2008) [38] proposed that finding bipartite connected subnetworks or bicliques in SL 
networks can help to identify groups of proteins belonging to redundant pathways. To this 
end, they searched for bicliques among SL interactions, and were able to identify several 
interesting relationships between pathways governing functions including DNA repair and 
DNA replication, and tubulin folding and mitosis. Brady et al. (2009) [39] further extended 
this approach to search for structures that they called stable bipartite subgraphs, and 
identified several new pairs of redundant pathway relationships. 
 
 
 
 
 
4. Pathways in dysregulated functions and diseases 
 
Many diseases, including cancer, result from dysregulated pathways and their complex 
interactions, and it is becoming increasingly clear that mapping these pathways is crucial to 
fully understand these complex diseases. This requires integrating diverse information from 
gene expression, mutation and regulation, protein interaction datasets and others; this has 
prompted integrative or “multi-omics” research towards pathway identification. Early work 
by Schadt et al. (2005) [40] and Tu et al. (2006) [41] focused on identifying possible linkages 
between (causal) mutations in DNA sequences or genes, and differentially expressed 
(target) genes under disease conditions. Their aim was to trace paths of differential 
expression from the targets back to the causal genes; these paths were hypothesised to 
constitute dysregulated pathways in the disease. Both groups approached this by looking for 
paths between target and causal genes through PPI networks. The interactions in the 
network were scored based on the correlation between each gene in the network and the 
target genes. Tu et al. simulated random walks from target genes, and the most frequently 
visited causal genes were evaluated for possible mutational characteristics, while the 
corresponding paths were analysed for involvement in disease mechanisms. 
 
Following these approaches, several methods were devised to simulate flows to identify 
paths between causal and target genes. An important method by Suthram et al. [42] in 2008 
used electric-circuit-based modelling [43] to simulate flows in the network. The motivation 
was that the random-walk-based methods were stochastic and required many simulations 
(about 10000 times in Tu et al.) to determine the causal gene. To propose a deterministic 
steady-state solution, Suthram et al. equated these random walks to the flow of electric 
current, and solved the network using electric-circuit theory (Kirchhoff's and Ohm's Laws). 
Equating the amount of current flow through each node and edge in the network to the 
expression level and importance of the genes, they could determine the ‘true’ causal genes 
with high accuracy. 
 
The electric circuit method was successfully adopted by Kim et al. (2009) [44] in the study of 
glioblastoma multiforma. They selected a set of differentially expressed target genes that 
covered 158 glioblastoma cases, and then identified possible genomic loci harbouring causal 
genes responsible for the differential expression of target genes. By overlaying a human PPI 
network, Kim et al. found probable paths from target to causal genes for which they used 
the electric-circuit model of Suthram et al. The causal genes identified were then evaluated 
for the disease cases they covered. Gene Ontology-based analysis of the identified pathways 
showed high enrichment of processes involved in glioblastoma. Following this success, He et 
al. [45] used a similar approach to identify dysfunctional genes and modules in congenital 
heart disease (CHD). 
 
 
 
 
 
5. Role of computational methods in future breakthroughs 
 
Among the kinds of genetic interactions, synthetic lethality (SL) describes a scenario in 
which single-gene defects are compatible with cell viability but a combination of gene 
defects results in cell death [46]. In essence, these SL interactions provide functional 
buffering, sometimes described as genetic canalisation, that is, buffering of pathways 
against the tendency of new alleles or mutated genes to make non-optimal phenotypes 
[47]. With the assembling of major pathways involved in core cellular processes affected in 
cancer, including DNA replication, DNA damage repair and cell-cycle checkpoints, it is now 
clear that buffering among pathways maintains viability in cancerous cells, potentially 
weakening anti-cancer therapies aimed at blocking individual pathways. However on the 
positive side, this hints that “sweet spots” capable of overcoming such compensatory 
arrangements can be identified that may lead to effective anti-cancer strategies in the 
future [48]. 
 
The PARP/BRCA relationship has become the poster child for SL-based cancer research 
today [48,49]. BRCA1 is a large protein expressed during the S and G2 phases of the cell 
cycle, and involved in the DNA double-strand break (DSB) repair pathway, one of several 
pathways required for maintaining DNA integrity. BRCA1-mutant cells have a defect in DNA 
damage repair, specifically in homologous recombination (HR)-mediated repair. In normal 
cells, the loss of BRCA1 activity is sensed in S-phase, resulting in immediate TP53-mediated 
cell death. However, tumor cells acquire a state in which repeated transit through S-phase 
can be accomplished despite loss of BRCA1 function. This leads to genomic instability and 
potential mutations in other crucial genes including p53 required to control cell 
proliferation.  A major breakthrough in BRCA1-mutant cancers was heralded by the finding 
that BRCA1 mutant cells are sensitive to PARP inhibitors. PARP1 is involved mainly in the 
DNA single-strand break (SSB) repair pathway. In the context of PARP inhibition, unrepaired 
SSBs accumulate into DSB equivalents upon entry into S-phase. In normal cells, these lesions 
are repaired by the HR-mediated DSB repair pathways. However, in the absence of BRCA1 
there may be greater reliance on PARP-mediated pathways, failing which DNA DSBs 
accumulate and lead to cell arrest and death. In essence, inhibition of PARP deals a double 
blow to BRCA1-deficient cells leading to cell death. Several PARP-inhibitor compounds are 
now under clinical or pre-clinical trials for use in anti-cancer therapy based on this concept 
[48]. 
 
Although the PARP/BRCA relationship is only a conditional one and not a panacea, it reflects 
the extent and kind of intricate relationships that need to be deciphered to map and 
understand the “pathway network”, and therefore to understand diseases like cancer. As 
Laubenbacher et al. [3] rightly put it as, “cancer is a systems biology disease”. While our 
current knowledge of pathways in cancer is still incomplete, immense efforts are underway 
to identify new players (genes, proteins and whole pathways) as well as to implicate existing 
ones in new roles – for example, the recent (2009) implication of a SUMO-mediated 
pathway in the BRCA1 response to genotoxic stress [50].  
 
Computational methods have a key role to play alongside experimental approaches. As an 
example, in recent remarkable research Rodriguez et al. [51] (2012) constructed a Boolean 
network model of the Fanconi anaemia/breast cancer (FA/BRCA) pathway to simulate the 
interstrand cross-links (ICL) repair process, whose inhibition is known to result in a 
chromosomal instability syndrome called Fanconi anaemia. Rodriguez et al. modelled 
knowledge of ICL as logical rules, obtaining a Boolean network of 28 nodes and 122 
regulatory interactions. These Boolean rules captured relationships among genes and 
pathways; for example, ICL can be responded to either by generating a DSB that is 
subsequently repaired by the BRCA1-mediated HR pathway, OR by bypassing this with the 
help of proliferation cell nuclear antigen (PCNA) and translesion synthesis (TLS) and 
repairing it with the nuclear excision (NER) pathway. Next, by fixing the loss- and gain-of-
function mutants as 0 or 1 in the network, they performed dynamical simulations to 
understand the state of the network, that is, the alternative pathways favoured under 
various mutational conditions. In this way they inferred key buffering mechanisms that may 
compensate for the defective FA/BRCA pathway, which are worth further research and 
experimental validation. 
 
 
 
 
 
6. Conclusions 
 
In order to decipher a correct and complete picture of cellular organisation, it is necessary 
to take a systems-level view. Mapping the molecular network is a crucial step toward this 
goal. However, mapping the entire network at one go can be daunting (and the current data 
are inadequate to support this), so mapping individual pathways is a rational way to 
proceed. Having said that, knowledge of individual pathways must be reflected back to the 
systems-level context, lest we miss the bigger picture.  
 Computational approaches have played a key role in identification and mapping of 
pathways. In this article, by drawing a roadmap of key contributions from computational 
approaches, and describing instances in which collective understanding of multiple 
pathways is necessary (for example, in cancer), we have attempted to put all these 
developments in a systems-level perspective. Future breakthroughs in understanding cellular 
mechanisms and diseases can come only by taking such a systems-level view. To this end, 
computational approaches will continue to play a key role. 
 
 
 
Key Points 
 
 Mapping the network of genes, proteins, RNA, and other molecules is a crucial step 
towards realizing the ‘systems biology goal’ of understanding cellular organisation. 
 
 Computational methods play a key role in this by complementing theoretical and 
experimental approaches. 
 
 We have highlighted key contributions of computational approaches in identification 
of signalling/regulatory pathways. These approaches have gone hand-in-hand with 
the improvements in high-throughput techniques, and have integrated diverse 
“omics” datasets. 
 
 Through these contributions, we reemphasize that computational methods have a 
key role in future breakthroughs in understanding cellular organization and also 
complex systems-level diseases like cancer. 
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